| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 72786-10-8 | (E)-4-[[(5Α,6Β)-17-(环丙基甲基)-4,5-环氧-3,14-二羟基吗啡-6-基]氨基]-4-氧-2-丁烯酸甲酯盐酸盐 | BETA-FUNALTREXAMINE HYDROCHLORIDE; (E)-[4-[[(5A,6B)-17-CYCLOPROPYLMETHYL]-4,5-EPOXY-3,14-DIHYDROXYMORPHINAN-6-YL]AMINO]-4-OXO-2-BUTENOICACID METHYL ESTER HYDROCHLORIDE; (E)-4-[[(5ALPHA,6BETA)-17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-3,14-DIHYDROXYMORPHINAN-6-YL]AMINO]-4-OXO-2-BUTENOIC ACID METHYL ESTER HYDROCHLORIDE; BETA-FUNALTREXAMINE; BETA-FUNALTREXAMINE HYDROCHLORIDE; BETA-FNA HYDROCHLORIDE; B-FUNALTREXAMINE HYDROCHLORIDE (B-FNA) S PECIFIC NON-EQUILIBR; BETA-FUNALTREXAMINE HCL; (E)-4-((5a,6b)-17-Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl)amino)-4-oxo-2-butenoicacidmethylesterhyd |  | C25H32ClN2O6 | 详情 | 供应商 |
| 20290-10-2 | 甲醇:水(1:1)测试标样(吗啡-6-Β-D-葡糖苷酸) | M-6-G TRIFLUOROACETATE-HYDRATE; MORPHINE-6-BETA-D-GLUCURONIDE TRIFLUOROACETATE-HYDRATE; M-6-G TRIFLUOROACETATE-HYDRATE; beta-d-phinan-6-alpha-yl; glucopyranosiduronicacid,7,8-didehydro-4,5-alpha-epoxy-3-hydroxy-17-methylmor; morphine-6-B-D-glucuronide dihydrate--*dea schedu; MORPHINE-6-B-D-GLUCURONIDE DIHYDRATE--*D EA SCHEDULE; MORPHINE-6-B-D-GLUCURONIDE MAJOR METABOL ITE OF M; (5a,6a)-7,8-Didehydro-4,5-epoxy-3-hydroxy-17-methylmorphinan-6-yl b-D-Glucopyranosiduronic Acid |  | C25H28F3NO11 | 详情 | 供应商 |
sitemap.xml